open access

Vol 9, No 4 (2020)
COVID-19 AND DIABETES
Published online: 2020-08-25
Get Citation

COVID-19 specialized diabetes clinic model for excellence in diabetes care: scientific perspective

Ahmed M. El-Malky, Abdulsalam S. Alharbi, Abdulkarim M. Alsaqabi, Wajood A. Alghammdi, Yasmin Jamal Albalawi, Turki Ibrahim Al-khalaf, Abdullah K. Alghutayghit, Abdullah S Alrufaidi, Salman W. Bafageeh, Abdulmajeed al Husain, Mohammed A. Ashour
DOI: 10.5603/DK.2020.0032
·
Clinical Diabetology 2020;9(4):208-211.

open access

Vol 9, No 4 (2020)
COVID-19 AND DIABETES
Published online: 2020-08-25

Abstract

While diabetes centers are well established by the Ministry of Health, there is no separate specialized diabetes clinics for COVID-19 patients (SDCs). There are several clinical diabetes centers throughout the Kingdom of Saudi Arabia, several of which have been developed through philanthropy funding; nevertheless, it is not obvious what distinguishes SDCs from a therapeutic viewpoint and what the potential would be for such centers. Through this context, we suggest a structure to direct the progress of SDCs. Defining protocols for wider adoption of SDCs as a means to enhance public safety and COVID-19 patient care efficiency (including consistency and satisfaction) and minimize health care expenses becomes increasingly essential when moving towards value-based sales and reimbursements away from service charges. It is wise to introduce innovative financial mechanisms to pay for diabetes that cannot be covered by fiscally limited private and university medical centers. We foresee potential clinical SDCs to be made up of a well-defined framework and six areas or foundations that act as basic guiding principles for the advancement of diabetes treatment skills that can be easily illustrated by stakeholders, including insurance facilities, consumers, payers and government departments.

Abstract

While diabetes centers are well established by the Ministry of Health, there is no separate specialized diabetes clinics for COVID-19 patients (SDCs). There are several clinical diabetes centers throughout the Kingdom of Saudi Arabia, several of which have been developed through philanthropy funding; nevertheless, it is not obvious what distinguishes SDCs from a therapeutic viewpoint and what the potential would be for such centers. Through this context, we suggest a structure to direct the progress of SDCs. Defining protocols for wider adoption of SDCs as a means to enhance public safety and COVID-19 patient care efficiency (including consistency and satisfaction) and minimize health care expenses becomes increasingly essential when moving towards value-based sales and reimbursements away from service charges. It is wise to introduce innovative financial mechanisms to pay for diabetes that cannot be covered by fiscally limited private and university medical centers. We foresee potential clinical SDCs to be made up of a well-defined framework and six areas or foundations that act as basic guiding principles for the advancement of diabetes treatment skills that can be easily illustrated by stakeholders, including insurance facilities, consumers, payers and government departments.

Get Citation

Keywords

COVID-19, specialized diabetes clinic, model for excellence, diabetes care

About this article
Title

COVID-19 specialized diabetes clinic model for excellence in diabetes care: scientific perspective

Journal

Clinical Diabetology

Issue

Vol 9, No 4 (2020)

Pages

208-211

Published online

2020-08-25

DOI

10.5603/DK.2020.0032

Bibliographic record

Clinical Diabetology 2020;9(4):208-211.

Keywords

COVID-19
specialized diabetes clinic
model for excellence
diabetes care

Authors

Ahmed M. El-Malky
Abdulsalam S. Alharbi
Abdulkarim M. Alsaqabi
Wajood A. Alghammdi
Yasmin Jamal Albalawi
Turki Ibrahim Al-khalaf
Abdullah K. Alghutayghit
Abdullah S Alrufaidi
Salman W. Bafageeh
Abdulmajeed al Husain
Mohammed A. Ashour

References (17)
  1. Zhu J, Kahn P, Knudsen J, et al. Predictive Model for Estimating the Cost of Incident Diabetes Complications. Diabetes Technol Ther. 2016; 18(10): 625–634.
  2. Stokes A, Preston SH. Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches. PLoS One. 2017; 12(1): e0170219.
  3. American Diabetes Association. Statistics about diabetes. 2013. http://www.diabetes.org/diabetes-basics/statistics/.
  4. Vigersky RA, Fish L, Hogan P, et al. The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab. 2014; 99(9): 3112–3121.
  5. Endocrinologist workforce to see double-digit shortage through 2025. Endocrine Insider, 10 July 2014.
  6. American College of Physicians. The patient-centered medical home neighbor: the interface of the patient-centered medical home with specialty/subspecialty practices [policy paper]. American College of Physicians, Philadelphia, PA. 2010.
  7. Siminerio L, Ruppert K, Huber K, et al. Telemedicine for reach, education, access, and treatment (TREAT): linking telemedicine with diabetes self-management education to improve care in rural communities. Diabetes Educ. 2014; 40(6): 797–805.
  8. Toledo FGS, Ruppert K, Huber KA, et al. Efficacy of the telemedicine for reach, education, access, and treatment (TREAT) model for diabetes care. Diabetes Care. 2014; 37(8): e179–e180.
  9. Chen A, Murphy EJ, Yee HF. eReferral: a new model for integrated care. N Engl J Med. 2013; 368(26): 2450–2453.
  10. Barnett ML, Yee HF, Mehrotra A, et al. Los Angeles Safety-Net Program eConsult System Was Rapidly Adopted And Decreased Wait Times To See Specialists. Health Aff (Millwood). 2017; 36(3): 492–499.
  11. Topol E. Digital medicine: empowering both patients and clinicians. Lancet. 2016; 388(10046): 740–741.
  12. Provost L. Building a learning health care system. In: 19th Annual Scientific Symposium on Improving the Quality and Value of Health Care. IHI National Forum; Orlano, FL, 9 December. 2013.
  13. Rother M. Toyota Kata. McGraw-Hill, New York, NY 2010.
  14. Imai M. Kaizen: The Key to Japan’s Competitive Success. Random House, New York, NY 1986.
  15. George ML. Lean six sigma: combining six sigma quality with lean production speed. McGraw-Hill Education, New York, NY 2002.
  16. Friedberg MW, Rosenthal MB, Werner RM, et al. Effects of a medical home and shared savings intervention on quality and utilization of care. JAMA Intern Med. 2015; 175(8): 1362–1368.
  17. Bouchonville MF, Paul MM, Billings J, et al. Taking telemedicine to the next level in diabetes population management: a review of the endo ECHO model. Curr Diab Rep. 2016; 16(10): 96.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl